Company Information

  

Address: 1000 WINTER STREET  
City: WALTHAM 
State: MA 
Zip Code: 02451 
Telephone: (781) 890-9989 

Description of Business

Primary SIC Code: 3841
(As filed with the SEC)  

NeuroMetrix is a commercial stage, innovation driven healthcare company combining neurostimulation and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. Our core expertise in biomedical engineering has been refined over nearly two decades of designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. We created the market for point-of-care nerve testing and were first to market with sophisticated wearable technology for management of chronic pain. We have an experienced management team and Board of Directors. Our business is fully integrated with in-house capabilities spanning product research and development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. We derive revenues from the sale of medical devices and after-market consumable products and accessories.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
There's no share overview data.

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2018 Leverage 2018
Net Inc/Comm Equity0.00Total Liab/Total Assets0.50
Net Inc/Total Assets0.00Total Liab/Inv Cap0.99
Net Inc/Inv Cap0.00Total Liab/Comm Equity0.03
Pretax Inc/Net Sales0.00Interest Coverage RatioNA
Net Inc/Net Sales0.00Curr Debt/EquityNA
Cash Flow/Net Sales0.18LTD/EquityNA
SG&A/NetSales0.90Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover15.09Quick Ratio1.46
Inventory Turnover3.48Current Ratio1.93
Inventory Day Sales0.01Net Rec/Curr Assets0.09
Net Sales/Work Cap2.87Inv/Curr Assets0.25
Net Sales/PP&E39.50  

Income Statement (Millions)

  6/30/2019 3/31/2019 12/31/2018 3/31/2018
Total Revenues(Net Sales) 2.35 3.12 3.73 4.94
Cost of Goods Sold 3.14 2.32 1.98 2.96
Selling & Admin Exps 2.94 3.64 3.51 4.31
Operating Income -4.76 -3.70 -2.82 -3.60
Interest Exp NA NA NA NA
Pretax Income -3.36 2.05 -2.80 1.17
Other Income 1.40 5.75 0.02 4.77
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -3.36 2.05 -2.80 1.17

Balance Sheet (Millions)

Assets 6/30/2019 3/31/2019 12/31/2018 3/31/2018
Cash & Short Term Investments 4.96 7.20 6.78 6.10
Receivables - Total 0.73 0.97 1.08 1.59
Inventories - Total 2.06 2.49 2.86 1.86
Total Current Assets 8.85 11.63 11.63 10.50
Net Property, Plant & Equipment 0.29 0.38 0.41 0.43
Total Assets 10.81 13.91 12.11 10.97
Liabilities        
Accounts Payable 4.84 4.32 4.06 4.15
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 4.84 4.50 6.02 4.15
Long-Term Debt NA NA NA NA
Total Liabilities 5.96 5.71 6.02 4.15
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -192.33 -188.97 -191.02 -189.87
Treasury Stock NA NA NA NA
Total Stockholders' Equity 4.86 8.19 6.10 6.82
Total Liabilities and Stockholders' Equity 10.81 13.91 12.11 10.97

Cash Flow Summary (Millions)

Categories 6/30/2019 3/31/2019 12/31/2018 3/31/2018
Net Cash Provided by Operating Activities -2.24 0.42 -0.72 2.08
Net Cash Provided by Investing Activities -0.01 0.00 -0.04 -0.03
Net Cash Provided by Financing Activities 0.01 NA 0.01 NA

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20145.51-7.77--
12/20157.30-9.19--
12/201612.03-14.91--
12/201717.09-12.86--
12/201816.090.02--
Growth Rates30.71----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/19347--




Report Date : 9/9/2019

Powered By Edgar Online © 2019EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.